Omar Oakes
May 8, 2018

GSK reviews global media

Pharma giant GlaxoSmithKline has reportedly launched a review of its US $1.8 billion global media agency arrangements, putting MediaCom and PHD on alert.

GSK reviews global media

The review, which is being handled by ID Comms, comes less than three years after GSK awarded its European business to MediaCom, while PHD was handed its US media account.

Both agencies had retained the accounts in 2015 following a global media review, after having been first appointed in 2013.

A year later, GSK completed an agency review for the other parts of its marketing comms business by hiring nine agencies, including Grey and Saatchi & Saatchi for advertising.

GSK's agencies were appointed to work on the company's seven power brands (Sensodyne, Parodontax, Poligrip, Voltaren, Panadol, Theraflu and Otrivin) and 12 core brands (Biotene, Contac, Flonase, Excedrin, Fenbid, Tums, ENO, Horlicks, Physiogel, Lamisil, Fenistil and Abreva/Zovirax).

GSK did not respond to a request for comment by Campaign UK by press time while MediaCom and PHD would not comment and referred Campaign to GSK.

Source:
Campaign UK

Related Articles

Just Published

1 hour ago

Move and win roundup: Week of March 8, 2021

Fig Health, Sandpiper Communications, Verizon Media and more, in our weekly collection of people moves and account news.

1 hour ago

Burger King appoints UM China

The Mediabrands agency will manage the brand's media planning and buying.

5 hours ago

Agency pins hopes on bullish crypto market as it ...

Cryptocurrency's recovery sparks revival of payment trend.

5 hours ago

Why NFTs have endless possibilities for brands

Brand marketers should take notice of this space.